44 related articles for article (PubMed ID: 21489802)
1. A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.
Bisacchi GS; Hale MR
Curr Med Chem; 2016; 23(6):520-77. PubMed ID: 26695512
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Anticancer Activity of 4β-Triazole-podophyllotoxin Glycosides.
Zi CT; Li GT; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM
Nat Prod Bioprospect; 2015 Apr; 5(2):83-90. PubMed ID: 25869591
[TBL] [Abstract][Full Text] [Related]
3. Ginsengenin derivatives synthesized from 20(
Guo HY; Xing Y; Sun YQ; Liu C; Xu Q; Shang FF; Zhang RH; Jin XJ; Chen F; Lee JJ; Kang D; Shen QK; Quan ZS
J Ginseng Res; 2022 Nov; 46(6):738-749. PubMed ID: 36312731
[TBL] [Abstract][Full Text] [Related]
4. Plant-Fungal Interactions: A Case Study of
Ogórek R; Przywara K; Piecuch A; Cal M; Lejman A; Matkowski K
Plants (Basel); 2020 Dec; 9(12):. PubMed ID: 33271933
[No Abstract] [Full Text] [Related]
5. Radiosensitization of Head and Neck Squamous Cell Carcinoma (HNSCC) by a Podophyllotoxin.
Resendez A; Tailor D; Graves E; Malhotra SV
ACS Med Chem Lett; 2019 Sep; 10(9):1314-1321. PubMed ID: 31531203
[TBL] [Abstract][Full Text] [Related]
6. Click chemistry-assisted synthesis of triazolo linked podophyllotoxin conjugates as tubulin polymerization inhibitors.
Vishnuvardhan MVPS; V SR; Chandrasekhar K; Lakshma Nayak V; Sayeed IB; Alarifi A; Kamal A
Medchemcomm; 2017 Sep; 8(9):1817-1823. PubMed ID: 30108892
[TBL] [Abstract][Full Text] [Related]
7. Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.
Liu YQ; Tian J; Qian K; Zhao XB; Morris-Natschke SL; Yang L; Nan X; Tian X; Lee KH
Med Res Rev; 2015 Jan; 35(1):1-62. PubMed ID: 24827545
[TBL] [Abstract][Full Text] [Related]
8. Toward synthesis of third-generation spin-labeled podophyllotoxin derivatives using isocyanide multicomponent reactions.
Kou L; Wang MJ; Wang LT; Zhao XB; Nan X; Yang L; Liu YQ; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2014 Mar; 75():282-8. PubMed ID: 24553146
[TBL] [Abstract][Full Text] [Related]
9. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.
Bailly C
Chem Rev; 2012 Jul; 112(7):3611-40. PubMed ID: 22397403
[No Abstract] [Full Text] [Related]
10. Topoisomerase inhibitors. A review of their therapeutic potential in cancer.
Sinha BK
Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
[TBL] [Abstract][Full Text] [Related]
12. An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
Kamal A; Kumar BA; Suresh P; Shankaraiah N; Kumar MS
Bioorg Med Chem Lett; 2011 Jan; 21(1):350-3. PubMed ID: 21144748
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
Na Y; Nam JM
Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel podophyllotoxin analogs.
Li J; Hua HM; Tang YB; Zhang S; Ohkoshi E; Lee KH; Xiao Zy
Bioorg Med Chem Lett; 2012 Jul; 22(13):4293-5. PubMed ID: 22658864
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
